Autologous T Cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Autologous T Cells, covering 2014-12-11 to 2023-09-15. Get the full timeline:
Most recent: Clinical Trial Update: Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009) [Phase 1]